Nucleic acid selection as a tool for drug discovery
- 1 June 1998
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 3 (6) , 265-273
- https://doi.org/10.1016/s1359-6446(97)01166-5
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Selexion: Systematic evolution of ligands by exponential enrichment with integrated optimization by non-linear analysisPublished by Elsevier ,2005
- DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice.Journal of Clinical Investigation, 1996
- Screening chemical libraries for nucleic-acid-binding drugs by in vitro selection: A test case with lividomycinMolecular Diversity, 1996
- Isolation of a nuclease-resistant decoy RNA that selectively blocks autoantibody binding to insulin receptors on human lymphocytes.The Journal of Experimental Medicine, 1996
- In vitro selection of RNA-based irreversible inhibitors of human neutrophil elastaseChemistry & Biology, 1995
- In Vitro Selection of RNA Ligands to Substance PBiochemistry, 1995
- Comprehensive Chemical Modification Interference and Nucleotide Substitution Analysis of an RNA Pseudoknot Inhibitor to HIV-1 Reverse Transcrip taseJournal of Molecular Biology, 1995
- RNA Selection: Aptamers achieve the desired recognitionCurrent Biology, 1994
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990